High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.8M
$3,779,898
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CFO
Other
|
2026-03-09 | $759,804x4 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Ragosa Mark
• CFO
10b5-1 SellΔOwn -36.8%
2026-03-09
$1,686,158Largex2
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CFO
10b5-1 SellΔOwn -36.8%
|
2026-03-09 | $1,686,158Largex2 | S | Form 4 |
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CFO
Other
|
2026-02-09 | $150,371x2 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Ragosa Mark
• CFO
10b5-1 SellΔOwn -30.4%
2026-02-09
$772,254x2
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CFO
10b5-1 SellΔOwn -30.4%
|
2026-02-09 | $772,254x2 | S | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Ragosa Mark
• CFO
10b5-1 SellΔOwn -38.6%
2026-01-08
$502,680
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CFO
10b5-1 SellΔOwn -38.6%
|
2026-01-08 | $502,680 | S | Form 4 |
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CFO
Other
|
2025-11-12 | $615,507 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Ragosa Mark
• CFO
10b5-1 SellΔOwn -39.0%
2025-11-12
$814,706
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CFO
10b5-1 SellΔOwn -39.0%
|
2025-11-12 | $814,706 | S | Form 4 |
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CFO
Other
|
2025-10-28 | $3,093 | M | Form 4 |
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CFO
10b5-1 Sell
|
2025-10-28 | $4,100 | S | Form 4 |